MediWound Ltd.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MDWD research report →
Companywww.mediwound.com
MediWound Ltd. , a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units.
- CEO
- Ofer Gonen
- IPO
- 2014
- Employees
- 111
- HQ
- Yavne, IL
Price Chart
Valuation
- Market Cap
- $183.47M
- P/E
- -9.07
- P/S
- 10.82
- P/B
- 4.96
- EV/EBITDA
- -12.87
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 19.19%
- Op Margin
- -149.06%
- Net Margin
- -140.80%
- ROE
- -65.79%
- ROIC
- -41.33%
Growth & Income
- Revenue
- $16.96M · -16.14%
- Net Income
- $-23,879,000 · 20.99%
- EPS
- $-2.10 · 30.69%
- Op Income
- $-25,279,000
- FCF YoY
- -0.69%
Performance & Tape
- 52W High
- $22.50
- 52W Low
- $14.90
- 50D MA
- $16.82
- 200D MA
- $17.64
- Beta
- 0.22
- Avg Volume
- 83.19K
Get TickerSpark's AI analysis on MDWD
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 18, 26 | Driver Vickie Rae | other | 0 |
| Mar 18, 26 | Driver Vickie Rae | other | 0 |
| Jun 29, 21 | Driver Vickie Rae | other | 14,285 |
| Jun 15, 22 | Driver Vickie Rae | other | 1,607 |
| May 16, 23 | Driver Vickie Rae | other | 5,357 |
| May 31, 24 | Driver Vickie Rae | other | 5,900 |
| Feb 26, 25 | Driver Vickie Rae | other | 7,542 |
| Feb 11, 26 | Driver Vickie Rae | other | 5,600 |
| Mar 18, 26 | Driver Vickie Rae | other | 6,250 |
| Mar 18, 26 | Luxenburg Kalfon Hana | other | 0 |
Our MDWD Coverage
We haven't published any research on MDWD yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MDWD Report →